Soligenix, Inc. posts annual revenue of $0.9489 million in 2022
Key fundamental financials
loss of $13.80 million
Revenue of $0.9489 million
Soligenix, Inc. [SNGX] has reported $13.80 million loss for the fiscal year ending Dec 31, 2022.
Revenue for the year was $0.9489 million with operating income of $14.24 million.
The Princeton, New Jersey (NJ)-based company operating in the pharmaceutical preparations sector with 15 employees has total shareholders equity of $2.47 million.